GLYCOPYRRONIUM
Manner of administration:Inhalation By Mouth
Restriction
Indication: Chronic obstructive pulmonary disease (COPD)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $59.70 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| seebri breezhaler | |||||
Manner of administration:Inhalation By Mouth
Restriction
Indication: Chronic obstructive pulmonary disease (COPD)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $105.62 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| seebri breezhaler | |||||
Manner of administration:Application
Restriction (Streamlined authority code: 18526)
Indication: Severe primary axillary hyperhidrosis
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 2 | DPMQ: $160.21 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Axhidrox | |||||
